General MedicationsINHALATIONStandard
FORANE
ISOFLURANE
Standard Dose
99.9%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview FORANE is listed in Drugs@FDA under application 017624 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient ISOFLURANE Form and strength LIQUID;INHALATION - 99.9% Sponsor BAXTER HLTHCARE Submission history Latest submission status date: 2024-12-09 00:00:00.
Structured Monograph
Clinical summary
Approval overview FORANE is listed in Drugs@FDA under application 017624 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ISOFLURANE Form and strength LIQUID;INHALATION - 99.9% Sponsor BAXTER HLTHCARE Submission history Latest submission status date: 2024-12-09 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.